FDA approves first nasal spray diuretic for heart, liver and kidney disease
The FDA has approved bumetanide nasal spray for the treatment of edema. Depositphotos – By Bronwyn Thompson 2025 Sep 15 – The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent …